LIBTAYO cemiplimab 350 mg concentrate for solution for infusion

Medison Pharma Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: c0d05c6ad8719c42
Product Name: LIBTAYO cemiplimab 350 mg concentrate for solution for infusion
Artg Id: 320609
Artg Name: LIBTAYO cemiplimab 350 mg concentrate for solution for infusion
Sponsor: Medison Pharma Australia Pty Ltd
Company Detail Path: /organization/medison-pharma-australia-pty-ltd
Artg Date: 2020-07-17
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/ea10a544998ea10d30103bb18061ab07.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/7e459e71b0f4a2f932a8fde098ca1082.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

c0d05c6ad8719c42

Type

Standard